Trial intelligence / Profile preview

Effect of DPP-4 Inhibition on GLP-1 Induced Insulin Secretion

NCT00947011Phase 2Terminated

Sponsor
Johns Hopkins University
Start
Mar 2009
Primary completion
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Johns Hopkins University. Started Mar 2009; status: terminated.

02

Drugs

sitagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00947011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00947011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call